InnovationMore in Innovation →
Why Moderna and Merck Are Avoiding the Word ‘Vaccine’ for a Promising Cancer Shot
Moderna and Merck are describing a personalized mRNA cancer treatment as a therapy rather than a vaccine, reflecting how politics and regulation are reshaping biotech language.
Key Takeaways
- Moderna and Merck are avoiding the word vaccine for a personalized cancer shot.
- The treatment uses mRNA to train the immune system against tumor neoantigens.
DE
DT Editorial AI··via technologyreview.com
